title: Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation.
abstract: In amyloidosis associated with apolipoprotein A-I (ApoA-I), heart amyloid deposits are mainly constituted by the 93-residue ApoA-I N-terminal region. A recombinant form of the amyloidogenic polypeptide, named [1-93]ApoA-I, shares conformational properties and aggregation propensity with its natural counterpart. The polypeptide, predominantly in a random coil state at pH 8.0, following acidification to pH 4.0 adopts a helical/molten globule transient state, which leads to formation of aggregates. Here we provide evidence that fibrillogenesis occurs also in physiologic-like conditions. At pH 6.4, [1-93]ApoA-I was found to assume predominantly an alpha-helical state, which undergoes aggregation at 37 degrees C over time at a lower rate than at pH 4.0. After 7 days at pH 6.4, protofibrils were observed by atomic force microscopy (AFM). Using a multidisciplinary approach, including circular dichroism (CD), fluorescence, electrophoretic, and AFM analyses, we investigated the effects of a lipid environment on the conformational state and aggregation propensity of [1-93]ApoA-I. Following addition of the lipid-mimicking detergent Triton X-100, the polypeptide was found to be in a helical state at both pH 8.0 and 6.4, with no conformational transition occurring upon acidification. These helical conformers are stable and do not generate aggregated species, as observed by AFM after 21 days. Similarly, analyses of the effects of cholesterol demonstrated that this natural ApoA-I ligand induces formation of alpha-helix at physiological concentrations at both pH 8.0 and 6.4. Zwitterionic, positively charged, and negatively charged liposomes were found to affect [1-93]ApoA-I conformation, inducing helical species. Our data support the idea that lipids play a key role in [1-93]ApoA-I aggregation in vivo.
authors.affiliation: Department of Structural and Functional Biology, University of Naples Federico II, Italy.
authors.forename: Daria Maria
authors.initials: DM
authors.lastname: Monti
authors.forename: Fulvio
authors.initials: F
authors.lastname: Guglielmi
authors.forename: Maria
authors.initials: M
authors.lastname: Monti
authors.forename: Flora
authors.initials: F
authors.lastname: Cozzolino
authors.forename: Silvia
authors.initials: S
authors.lastname: Torrassa
authors.forename: Annalisa
authors.initials: A
authors.lastname: Relini
authors.forename: Piero
authors.initials: P
authors.lastname: Pucci
authors.forename: Angela
authors.initials: A
authors.lastname: Arciello
authors.forename: Renata
authors.initials: R
authors.lastname: Piccoli
mesh_terms: D000682:Amyloid / Q000737:chemistry* / Q000378:metabolism*; D016632:Apolipoprotein A-I / Q000737:chemistry*; D002784:Cholesterol / Q000494:pharmacology; D006801:Humans; D008024:Ligands; D008055:Lipids / Q000494:pharmacology*; D008081:Liposomes / Q000494:pharmacology; D017830:Octoxynol / Q000494:pharmacology; D010446:Peptide Fragments / Q000737:chemistry* / Q000378:metabolism*; D055503:Protein Multimerization / Q000187:drug effects*; D055550:Protein Stability / Q000187:drug effects; D017433:Protein Structure, Secondary / Q000187:drug effects
chemical_list: D000682:Amyloid; D016632:Apolipoprotein A-I; D008024:Ligands; D008055:Lipids; D008081:Liposomes; D010446:Peptide Fragments; D017830:Octoxynol; D002784:Cholesterol